|Min SIP Amount||Not Supported|
|NAV||₹11.21 (22 Jun 2021)|
|Fund Started||06 Apr 2018|
|Fund Size||₹133 Cr|
|State Bank of India||Financial||Equity||7.1%|
|Laxmi Organic Industries Ltd.||Chemicals||Equity||6.1%|
|ABB India Ltd.||Engineering||Equity||6.0%|
|Anupam Rasayan India Ltd.||Chemicals||Equity||5.4%|
|Fortis Healthcare Ltd.||Healthcare||Equity||5.1%|
|Bharat Forge Ltd.||Automobile||Equity||5.0%|
|Cummins India Ltd.||Engineering||Equity||4.5%|
|ICICI Bank Ltd.||Financial||Equity||4.1%|
|Indusind Bank Ltd.||Financial||Equity||3.8%|
|Axis Bank Ltd.||Financial||Equity||3.7%|
Aditya Birla Sun Life Resurgent India Fund Series 7 Direct Growth is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was made available to investors on 06 Apr 2018. Satyabrata Mohanty, Milind Bafna is the Current Fund Manager of Aditya Birla Sun Life Resurgent India Fund Series 7 Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹133 Cr and the Latest NAV as of 22 Jun 2021 is ₹11.21.
The Aditya Birla Sun Life Resurgent India Fund Series 7 Direct Growth is rated Very High risk.
The scheme seeks to provide capital appreciation by investing primarily in equity and equity related securities that are likely to benefit from recovery in the Indian economy.